Proceedings of the 3rd International Genomic Medicine Conference: cancer
Publication of this supplement has been supported by the Centre of Excellence in Genomic Medicine Research. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.
Jeddah, Saudi Arabia
30 November - 3 December 2015
Edited by Muhammad Abu-Elmagd.
- RESEARCH ARTICLE
Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi ArabiaRenal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find ...BMC Cancer 2016 16(Suppl 2):741Published on: 30 September 2016
In vitro models of cancer stem cells and clinical applicationsCancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that ...BMC Cancer 2016 16(Suppl 2):738Published on: 30 September 2016
No hay comentarios:
Publicar un comentario